I was replying to Whichway4$ about Morningstar valuations being useless, and in my opinion Bell Potter's valuations are more useless, giving one example of Elixinol (EXL - take a look for yourself at their 5Y chart). Whether I acted on it or not is irrelevant. EXL is also not the only example of their poor valuations, it just happens to be one I had personal experience with. I also didn't "blindly buy" based on a broker review, but they influenced me, as I'm sure you were influenced to buy A2M.
Ann: Ceasing to be a substantial holder, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.61 |
Change
-0.020(0.36%) |
Mkt cap ! $4.061B | |||
| Open | High | Low | Value | Volume |
| $5.69 | $5.74 | $5.60 | $10.03M | 1.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4199 | $5.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.64 | 2719 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| A2M (ASX) Chart |